InvestorsHub Logo
Followers 19
Posts 1991
Boards Moderated 0
Alias Born 02/25/2017

Re: GreatWhiteBuffalo post# 52443

Saturday, 04/15/2017 7:00:47 PM

Saturday, April 15, 2017 7:00:47 PM

Post# of 106837
To me it's relevant now, in that, RMAT takes in clinical evidence OUTSIDE of current trials as well. Yes, US Stem Cell may have limited patients in their "clinical trials", but they have a TON of data like this from South America, Europe, and Asia. I'm sure the FDA is also reviewing that data in addition to the phase 2/3 marvel data.